{"id":4437,"date":"2025-03-31T18:12:08","date_gmt":"2025-03-31T18:12:08","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/tropisetron-txt\/"},"modified":"2025-03-31T18:12:08","modified_gmt":"2025-03-31T18:12:08","slug":"tropisetron-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/tropisetron-txt\/","title":{"rendered":"Tropisetron.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3>  Anti-emetic: Cancer chemotherapy   Postoperative nausea and vomiting   (PONV) <H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3> Chemotherapy: IV bolus or infusion of   5 mg before chemotherapy, then 5 mg every morning orally for 5 days PONV: IV bolus or infusion of 2 mg before   induction of anaesthesia, then 2 mg within 2 hours of the end of surgery <H3>  PHARMACOKINETICS    <\/H3> <LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 284.4 (320.8 as hydrochloride) <\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 71 <\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 8 (70% as metabolites) <\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp : 400\u2013600 litres <\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp : 8\u201345 (depends on metaboliser status)\/ Increased <H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4> <LI> 20 to 50  &amp;nbsp &amp;nbsp : Dose as in normal renal function <LI> 10 to 20  &amp;nbsp &amp;nbsp : Dose as in normal renal function <LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Dose as in normal renal function <H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3> <LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp: Unlikely to be dialysed. Dose as in normal renal function <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Unlikely to be dialysed. Dose as in normal renal function <LI>HDF\/high flux  &amp;nbsp : Unknown dialysability. Dose as in normal renal function <LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp: Unknown dialysability. Dose as in normal renal function <H3> IMPORTANT DRUG INTERACTIONS  <\/H3> Potentially hazardous interactions with other drugs\n<li>Anti-arrhythmics: increased risk of   ventricular arrhythmias \u2013 use with caution; avoid with amiodarone, disopyramide, flecainide, lidocaine, mexiletine, procainamide or propafenone\n<li>Beta-blockers: increased risk of ventricular   arrhythmias \u2013 use with caution; avoid with sotalol <H3> ADMINISTRATION  <\/H3> <H4> Reconstition<\/H4> \u2013   <H4>  Route  <\/H4> Oral, IV bolus, <H4> IV infusion  <\/H4>   <H4>  Rate of Administration  <\/H4> Bolus: over at least 1 minute   Infusion: over 15 minutes   <H4>Comments<\/H4> Can be added to 100 mL sodium chloride   0.9%, glucose 5% or Ringer\u2019s solution Give oral preparation at least an hour   before food <H4>  OTHER INFORMATION  <\/H4> In impaired kidney function, plasma   concentrations of tropisetron may be increased by up to 50%, but no problem with short courses .<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Anti-emetic: Cancer chemotherapy Postoperative nausea and vomiting (PONV)<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4437","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4437"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4437\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}